Clinical trial · Observational
LDCT Screening in Non-smokers in Taiwan
Low Dose Computed Tomography Screening Study in Non-smokers with Risk Factors for Lung Cancer in Taiwan
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study utilizes the low dose computed tomography(LDCT) to detect the occurrence of early lung cancer among non-smokers in Taiwan. Subjects who have family history of lung cancer or have high risk exposures to lung cancer will be recruited to participate LDCT screening and followed up for their possible occurrence of lung cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| LDCT | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Non-smokers at risk for lung cancer
- description
- 1. Non-smoking subjects with lung cancer family history 2. Non-smoking subjects with a given lung cancer risk other than lung cancer family history
- interventionNames
- Other: LDCT
Primary outcomes (1)
- measure
- Validity of LDCT for lung cancer among non-smokers
- timeFrame
- 3 years
- description
- True positive, false positive, true negative and false negative rates of LDCT on lung cancer screening. Each subject who is recognized as high risk to lung cancer will be recruited between 2014-2016.
Secondary outcomes (2)
- measure
- Monitoring the occurrence of lung cancer
- timeFrame
- 5 years
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: 1. Never smokers or have smoked less than 10 pack-years and quitted smoking over 15 years. 2. age from 55 to 75 years for subjects without lung cancer family history; age 50-75 years for subjects with lung cancer family history (age less than 50 but older than the age at diagnosis of the youngest lung cancer proband is also eligible) 3. Having at least one of the following conditions: (1)with family history of lung cancer within 1st, 2nd or 3rd degree relatives (2)with exposure history of environmental tobacco smoke in workplace or in home (3)history of chronic lung disease (Tuberculosis or COPD) (4)the cooking index equal or over than 110 \[cooking index = 2/7 x (days of cooking by pan frying, stir frying, or deep frying in one week) x (cooking years)\] (5)cooking without using cooking ventilation Exclusion Criteria: 1. with history of lung cancer, or with cancers except skin cancer or cervical carcinoma in situ in the past 5 years 2. can not accept invasive diagnostic procedure or surgery 3. have been examined by chest computed tomography in the past 18 months 4. have unexplained hemoptysis in one month 5. weight loss over than 6 kg with unexplained reason among one year 6. pregnant
References
Publications (65)
- BACKGROUNDSiegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7. PMID 24399786
- BACKGROUNDInternational Early Lung Cancer Action Program Investigators; Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006 Oct 26;355(17):1763-71. doi: 10.1056/NEJMoa060476. PMID 17065637
- BACKGROUNDField JK, Oudkerk M, Pedersen JH, Duffy SW. Prospects for population screening and diagnosis of lung cancer. Lancet. 2013 Aug 24;382(9893):732-41. doi: 10.1016/S0140-6736(13)61614-1. PMID 23972816
- BACKGROUNDMelamed MR, Flehinger BJ, Zaman MB, Heelan RT, Perchick WA, Martini N. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest. 1984 Jul;86(1):44-53. doi: 10.1378/chest.86.1.44. PMID 6734291
- BACKGROUNDOken MM, Hocking WG, Kvale PA, Andriole GL, Buys SS, Church TR, Crawford ED, Fouad MN, Isaacs C, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Rathmell JM, Riley TL, Wright P, Caparaso N, Hu P, Izmirlian G, Pinsky PF, Prorok PC, Kramer BS, Miller AB, Gohagan JK, Berg CD; PLCO Project Team. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA. 2011 Nov 2;306(17):1865-73. doi: 10.1001/jama.2011.1591. Epub 2011 Oct 26. PMID 22031728
- BACKGROUNDSobue T, Moriyama N, Kaneko M, Kusumoto M, Kobayashi T, Tsuchiya R, Kakinuma R, Ohmatsu H, Nagai K, Nishiyama H, Matsui E, Eguchi K. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol. 2002 Feb 15;20(4):911-20. doi: 10.1200/JCO.2002.20.4.911. PMID 11844811
- BACKGROUNDHenschke CI. Early lung cancer action project: overall design and findings from baseline screening. Cancer. 2000 Dec 1;89(11 Suppl):2474-82. doi: 10.1002/1097-0142(20001201)89:11+3.3.co;2-u.